1.
Zhivaki D, Kennedy SN, Park J, et al. Correction of age-associated defects in dendritic cells enables CD4 T cells to eradicate tumors. Cell. 2024. doi:10.1016/j.cell.2024.05.026.
1.
Wang H, Divaris K, Pan B, et al. Clonal hematopoiesis driven by mutated DNMT3A promotes inflammatory bone loss. Cell. 2024. doi:10.1016/j.cell.2024.05.003.
1.
Wang H, Divaris K, Pan B, et al. Clonal hematopoiesis driven by mutated DNMT3A promotes inflammatory bone loss. Cell. 2024. doi:10.1016/j.cell.2024.05.003.
1.
Wang H, Divaris K, Pan B, et al. Clonal hematopoiesis driven by mutated DNMT3A promotes inflammatory bone loss. Cell. 2024. doi:10.1016/j.cell.2024.05.003.
1.
Parry EM, Lemvigh CK, Deng S, et al. ZNF683 marks a CD8 T cell population associated with anti-tumor immunity following anti-PD-1 therapy for Richter syndrome. Cancer cell. 2023. doi:10.1016/j.ccell.2023.08.013.
1.
Panagoulias I, Charokopos N, Thomas I, et al. Shifting gears: Study of immune system parameters of male habitual marathon runners. Frontiers in immunology. 2022;13:1009065. doi:10.3389/fimmu.2022.1009065.